Shuttle Pharmaceuticals Holdings, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SHPH, updated each market day.
SHPH AI Sentiment
AI predicts Shuttle Pharmaceuticals Holdings, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
Sector
Exchange
Market Cap
$5,204,101
Cap Tier
Employees
2
Headquarters
GAITHERSBURG, MD
Listed Since
Aug. 31, 2022
Website
SHPH Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SHPH Volatility
Shuttle Pharmaceuticals Holdings, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
